Reuters Health Information (2011-09-20): Hepatitis C drug Incivo (telaprevir) gets EU nod
Hepatitis C drug Incivo (telaprevir) gets EU nod
Last Updated: 2011-09-20 18:55:29 -0400 (Reuters Health)
(Reuters) - Vertex Pharmaceuticals Inc and partner Johnson & Johnson won European approval for their hepatitis C drug telaprevir, Vertex said on Tuesday.
The pill won U.S. approval in May. Known as Incivek in the United States, it will be called Incivo in Europe.
Telaprevir can nearly double the chances of curing hepatitis C compared with prior standard treatments.
Approval for the drug in Europe was expected after the European Medicines Agency recommended it in July.